Label Changes for:
Pristiq (desvenlafaxine) Extended-Release Tablets
February 2013
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
February 2013

